Clinical Trials on HER2-positive Solid Cancers in Korea, Republic of
Total 288 results
-
Samsung Medical CenterCompletedHER2-positive Refractory Advanced CancerKorea, Republic of
-
Gangnam Severance HospitalSeoul National UniversityRecruitingBreast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive Tumor | Premenopausal Breast Cancer | Node-positive Breast CancerKorea, Republic of
-
Yuhan CorporationRecruitingHER2-Positive Solid TumorKorea, Republic of, Australia
-
Alteogen, Inc.CompletedHER2-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterRecruitingHER2-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterUnknownHER2-positive Breast CancerKorea, Republic of
-
Korean Cancer Study GroupUnknownPhase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast CancerMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
National Cancer Center, KoreaActive, not recruitingMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Yonsei UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | PostmenopausalKorea, Republic of
-
Samsung Medical CenterActive, not recruitingHER2-positive Breast Cancer | Chemotherapy Effect | Circulating Tumor DNAKorea, Republic of
-
Yonsei UniversityNot yet recruitingHER2-positive Gastric CancerKorea, Republic of
-
Samsung Medical CenterActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Kangbuk Samsung HospitalRecruitingHER2-positive Advanced Gastric CancerKorea, Republic of
-
Yonsei UniversityCompletedHER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract CancerKorea, Republic of
-
Bristol-Myers SquibbCompletedSolid Tumors That Overexpress HER2 (HER2 Positive)United States, Canada
-
Yonsei UniversityNot yet recruitingHER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract CancerKorea, Republic of
-
Gangnam Severance HospitalSamsung Medical Center; Asan Medical Center; Severance HospitalRecruitingBreast Cancer | Surgery | Recurrent Breast Cancer | Estrogen Receptor Positive Tumor | Stereotactic Body Radiotherapy | Her2-negative TumorKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedNational OncoVentureCompletedHER-2 Positive Advanced Gastric CancerKorea, Republic of
-
Samsung Medical CenterCompletedHER2-positive Gastric Cancer Patients With Liver MetastasisKorea, Republic of
-
Bolt Biotherapeutics, Inc.Bristol-Myers SquibbActive, not recruitingHER2-positive Breast Cancer | HER2-positive Colorectal Cancer | HER2-positive Solid Tumors | HER2-positive Gastroesophageal Cancer | HER2-positive Endometrial CancerFrance, United States, Spain, Korea, Republic of, Italy
-
Sung Yong OhCelltrionUnknownMetastatic Cancer | HER-2 Positive Gastric CancerKorea, Republic of
-
Asan Medical CenterHoffmann-La RocheCompletedMetastatic or Recurrent Gastric Adenocarcinoma | Her-2 Positive Gastric CancerKorea, Republic of
-
Korea University Guro HospitalKorean Cancer Study GroupActive, not recruitingMetastatic Cancer | HER2 Gene MutationKorea, Republic of
-
Panolos BioscienceRecruitingMetastatic Colorectal Cancer | Hepatocellular Carcinoma | Gastric Cancer | Solid Tumor | Advanced Solid Tumor | Solid Tumor, AdultKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedCompletedSolid Tumor | Advanced CancerKorea, Republic of
-
Silverback TherapeuticsActive, not recruitingHER2 Positive Solid TumorsUnited States, Korea, Republic of, Australia
-
Yonsei UniversityRecruitingTriple Negative Breast Cancer | Metastatic Breast Cancer With HER2 PositiveKorea, Republic of
-
EnhancedBio USA Inc.ZenopharmRecruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | HER2-Negative | Estrogen Receptor-PositiveUnited States, Korea, Republic of
-
Gangnam Severance HospitalRecruitingHER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 StudyKorea, Republic of
-
Samsung Medical CenterNot yet recruitingPremenopausal HR+/HER2- Metastatic Breast CancerKorea, Republic of
-
Seoul National University HospitalPfizerCompletedAdvanced Gastric Cancer | HER2Korea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedAdvanced Solid CancersKorea, Republic of
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
Seoul National University HospitalActive, not recruitingHormone Receptor-positive Breast Cancer | Premenopausal Breast CancerKorea, Republic of
-
Seoul National University HospitalActive, not recruitingInvasive Breast Cancer | Estrogen Receptor Positive Breast CancerKorea, Republic of
-
Gencurix, Inc.RecruitingEarly Hormone Receptor-positive Breast CancerKorea, Republic of
-
Pieris Pharmaceuticals, Inc.Active, not recruitingHER2-positive Gastric CancerUnited States, Korea, Republic of
-
Samsung Medical CenterAsan Medical Center; Seoul National University Hospital; Ulsan University Hospital and other collaboratorsUnknownMetastatic Breast Cancer | Estrogen Receptor Positive Tumor | Breast Cancer Nos PremenopausalKorea, Republic of
-
Yonsei UniversityCompletedPancreatic Cancer | Solid Pancreatic and Peripancreatic LesionKorea, Republic of
-
CJ Bioscience, Inc.RecruitingMelanoma | NSCLC | Metastatic Cancer | Advanced Solid Tumor | Advanced Cancer | HNSCCKorea, Republic of
-
Daehwa Pharmaceutical Co., Ltd.CompletedSolid Tumor | Stage IV Gastric CancerKorea, Republic of
-
Elevar TherapeuticsBukwang Pharmaceutical, Co., Ltd.CompletedCancer Patients With Solid TumorsKorea, Republic of, United States
-
Samsung Medical CenterCompletedc-MET Positive Gastric CancerKorea, Republic of
-
Changhoon YooCompletedCholangiocarcinoma | Biliary Tract Cancer | HER-2 Gene Amplification | HER-2 Protein OverexpressionKorea, Republic of
-
CinnagenCompletedHER2-positive Breast CancerIran, Islamic Republic of
-
Samsung Medical CenterAstraZenecaUnknownEGFR Mutation Positive Non-small Cell Lung CancerKorea, Republic of
-
Eli Lilly and CompanyActive, not recruitingPancreatic Cancer | Solid Tumor | Cutaneous Melanoma | Microsatellite Instability-High (MSI-H) Solid Tumors | Breast Cancer (HR+HER2-)Belgium, Spain, Korea, Republic of, United States, Taiwan, France, Canada
-
Handok Inc.ABL Bio, Inc.; Compass TherapeuticsActive, not recruitingP1b: Advanced Solid Tumors | P2: Biliary Tract CancerKorea, Republic of
-
GI Biome, Inc.RecruitingCancer | Colorectal Cancer | Rectal Cancer | Solid Tumor | Sigmoid Colon Cancer | Rectosigmoid Junction CancerKorea, Republic of
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast Cancer or Gastric CancerTaiwan, Netherlands, Italy, United States, Belgium, United Kingdom, Korea, Republic of, France, Spain